Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;179(5):2533-50.
doi: 10.1016/j.ajpath.2011.07.044. Epub 2011 Sep 23.

Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease

Affiliations

Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease

Laurel Vana et al. Am J Pathol. 2011 Nov.

Abstract

Tau is a microtubule-associated protein that forms neurofibrillary tangles (NFTs) in the selective vulnerable long projection neurons of the cholinergic basal forebrain (CBF) in Alzheimer's disease (AD). Although CBF neurodegeneration correlates with cognitive decline during AD progression, little is known about the temporal changes of tau accumulation in this region. We investigated tau posttranslational modifications during NFT evolution within the CBF neurons of the nucleus basalis (NB) using tissue from subjects with no cognitive impairment, mild cognitive impairment, and AD. The pS422 antibody was used as an early tau pathology marker that labels tau phosphorylated at Ser422; the TauC3 antibody was used to detect later stage tau pathology. Stereologic evaluation of NB tissue immunostained for pS422 and TauC3 revealed an increase in neurons expressing these tau epitopes during disease progression. We also investigated the occurrence of pretangle tau events within cholinergic NB neurons by dual staining for the cholinergic cell marker, p75(NTR), which displays a phenotypic down-regulation within CBF perikarya in AD. As pS422+ neurons increased in number, p75(NTR)+ neurons decreased, and these changes correlated with both AD neuropathology and cognitive decline. Also, NFTs developed slower in the CBF compared with previously examined cortical regions. Taken together, these results suggest that changes in cognition are associated with pretangle events within NB cholinergic neurons before frank NFT deposition.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Difference between clinical diagnosis and neuropathological score. Histograms demonstrating the percentage of cases in each clinical group (NCI (light gray), MCI (black), and AD (dark gray), versus Braak score (A) and NIA Reagan diagnosis (B). These histograms indicate that there are several NCI and MCI cases with higher than expected Braak scores and NIA Reagan diagnoses.
Figure 2
Figure 2
p75NTR/pS422 Immunolabeled neurons. Sections containing the NB subfield of the CBF dual immunostained for p75NTR+ (brown) and pS422+ (blue) show a decrease in the number of p75NTR+ neurons with an increase of pS422+ neurons as disease progression continues from NCI (A and B), to MCI (C and D) and AD (E and F). In NCI (B), most NB neurons were single-labeled for p75NTR+ (asterisk), few neurons were double-labeled for p75NTR+/pS422+ (black arrow), whereas only an occasional neuron was single-labeled for the early tau pathological marker, pS422+ (green arrow). In the MCI (D) and AD (F) cases, there was a decrease in the p75NTR+ neurons (asterisk) and an increase in both p75NTR+/pS422+ (black arrow) and pS422+ (green arrow) neurons. In some p75NTR+/pS422+ neurons, it can be seen that the pS422 immunoreactivity begins in the center of the neuron (blue arrow). Images in A, C, and E were taken at magnification ×4. Scale bar = 250 μm. Images in B, D, and F were taken at magnification×20. Scale bar is 50 μm. The panels to the right were taken at magnification ×60. Scale bar is 25 μm.
Figure 3
Figure 3
Quantification of the p75NTR and pS422 double-stain. Box plots showing an increase in the number of pS422+ (A) and p75NTR+/pS422+ (B) neurons from NCI to MCI and AD. C: p75NTR+ Neurons decreased from NCI to MCI and AD.
Figure 4
Figure 4
Neuropathological and clinical correlates in p75NTR and pS422 double-stain. Bar charts plotting mean and SEM show an increase in number of pS422+ (A) and p75NTR+/pS422+ (B) compared with a decrease in p75NTR+ (C) neurons across Braak stage of NFT pathology. The increase in pS422+ (A) and p75NTR+/pS422+ (B) neurons showed a strong positive correlation with Braak score, and the loss of p75NTR+ neurons showed a negative correlation with Braak score (C). Scatterplots showed that a strong negative correlation was also observed between pS422+ (D) and p75NTR+/pS422+ (E) neurons and GCS. r = Spearman rank correlation.
Figure 5
Figure 5
pS422 and TauC3 immunolabeled neurons. NB tissue immunohistochemically stained for pS422+ (brown) and TauC3+ (blue) within the CBF demonstrating an increase the number of pS422+, pS422+/TauC3+, and TauC3+ neurons from NCI (A and B), to MCI (C and D) and to AD (E and F). In most NCI cases (B), single-label pS422+ neurons were sparse (asterisk), and many pS422 immunoreactive neurons displayed very light staining (red arrow). In MCI (D), there was an increase in pS422+ (asterisk) neurons and the appearance of both pS422+/TauC3+ (black arrow) and TauC3+ neurons (green arrow). In AD (F), there was an increase in all three neuronal phenotypes for pS422+ (asterisk), pS422+/TauC3+ (black arrow) and TauC3+ (green arrow). Images in A, C, E taken at × 10 and scale bar is 250 μm. Images in B, D, F were taken at × 20 and scale bar is 50 μm. Images to the right were taken at × 60 and scale bar is 25 μm.
Figure 6
Figure 6
Quantification of pS422 and TauC3 double-stain. Box plots showing an increase in the number of pS422+ neurons (A) and pS422+/TauC3+ neurons (B) in MCI and AD. C: Appearance of TauC3+ neurons was variable across the cognitive diagnosis groups.
Figure 7
Figure 7
Quantification and correlations of pS422+ NT length. Photomicrograph showing an example of pS422+ NTs within the NB in an AD case (A) Scale bar = 25 μm. The box plots demonstrate an increase in pS422+ NT length in MCI and AD (B). C: Bar chart plotting mean and SEM shows that the increase in NT length significantly correlated with severity of Braak stage. D: Scatterplot showing a significant negative correlation between GCS and pS422+ thread length.
Figure 8
Figure 8
Dual immunofluoresence of p75NTR and pS422. Immunofluoresence of p75NTR+ (green) and pS422+ (red) neurons in the NB revealed a large number of p75NTR+ neurons (A) and pS422+ NTs (B) most commonly seen in NCI cases (A–C). In MCI, p75NTR+ neurons (D) were also labeled with pS422 (E and F). In AD, p75NTR+ neurons were still seen (G), but there was an increase in the number of pS422+ neurons (H) that co-labeled with p75NTR (I). All images taken at magnification ×63. Scale bar = 25 μm.
Figure 9
Figure 9
p75NTR and TauC3 do not colocalize. p75NTR+ (green) and TauC3+ (red) immunofluorescence within the NB revealed that most neurons were p75NTR+ (A). Virtually no TauC3+ neurons (B and C) were found in NCI. In MCI, there were many p75NTR+ neurons (D) and the appearance of, TauC3+ neurons (E) that did not colocalize with p75NTR (F). In AD, p75NTR+ neurons were still present (G) but there were many more TauC3+ neurons (H). In most cases, TauC3+ cells lacked p75NTR reactivity (I). All images taken at magnification ×63. Scale bar = 25 μm.

Comment in

Similar articles

Cited by

References

    1. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol. 1983;214:170–197. - PubMed
    1. Mesulam M.M., Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol. 1988;275:216–240. - PubMed
    1. Wilcock G.K., Esiri M.M. Plaques, tangles and dementia: A quantitative study. J Neurol Sci. 1982;56:343–356. - PubMed
    1. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., Perl D.P., Schmeidler J., Kanof P., Davis K.L. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem. 1995;64:749–760. - PubMed
    1. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982;215:1237–1239. - PubMed

Publication types